Literature DB >> 23103249

Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome.

J Nemeth1, B Ledergerber, B Preiswerk, A Nobile, S Karrer, C Ruef, S P Kuster.   

Abstract

BACKGROUND: Worldwide, the burden of multidrug-resistant bacteria (MDR) is increasing, especially in the hospital setting. AIM: To explore characteristics and clinical relevance of MDR obtained from travellers transferred from hospitals abroad.
METHODS: This retrospective study included patients transferred from hospitals abroad to the University Hospital Zurich, Switzerland, who routinely underwent admission screening for possible colonization with meticillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamase-producing bacteria (ESBL) and multidrug-resistant Gram-negative bacteria (MR Gram negative).
FINDINGS: Forty-six (17%) of 259 subjects were found to be colonized with MDR and nine (3.5%) patients to be infected. Thirty-three (12%) patients were colonized with one bacterial species, 12 (4.6%) with two, and three (1.2%) were colonized with three different bacterial species. In total, 36 ESBL, 21 MR Gram-negative and three MRSA isolates were detected. Escherichia coli (N = 18, 30%), Klebsiella pneumoniae (N = 14, 23%) and Acinetobacter baumannii (N = 14, 23%) were most frequently isolated. The most common sites of detection were skin (97%) and respiratory tract (41%). Being colonized contributed to an increased length of ICU stay [median (range): 8 (1-35) vs 3.5 (1-78) days; P = 0.011]. In-hospital mortality in patients colonized with MDR (10.9%) was higher than in uncolonized patients (2.3%, P = 0.018). Being colonized with MDR was associated with death (adjusted odds ratio: 5.176; 95% confidence interval: 1.325-20.218).
CONCLUSIONS: A substantial proportion of patients transferred from abroad are colonized with MDR, a fact which is associated with poor clinical outcome.
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23103249     DOI: 10.1016/j.jhin.2012.08.017

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  14 in total

Review 1.  Travel and the Spread of Drug-Resistant Bacteria.

Authors:  Kevin L Schwartz; Shaun K Morris
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

Review 2.  The Traveling Microbiome.

Authors:  Mark S Riddle; Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 3.  Infectious Complications of Transplant Tourism.

Authors:  Michele I Morris; Elmi Muller
Journal:  Curr Infect Dis Rep       Date:  2019-08-31       Impact factor: 3.725

4.  European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad.

Authors:  Mikael Kajova; Tamim Khawaja; Anu Kantele
Journal:  J Travel Med       Date:  2022-07-14       Impact factor: 39.194

Review 5.  Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level.

Authors:  Paul-Louis Woerther; Antoine Andremont; Anu Kantele
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

6.  Molecular epidemiology of multidrug-resistant clinical isolates of Acinetobacter baumannii : A 10-year analysis in a large tertiary care university hospital in central Europe with international admissions.

Authors:  Luigi Segagni Lusignani; Peter Starzengruber; Verena Dosch; Ojan Assadian; Elisabeth Presterl; Magda Diab-Elschahawi
Journal:  Wien Klin Wochenschr       Date:  2017-08-03       Impact factor: 1.704

7.  Colonization with resistant microorganisms in patients transferred from abroad: who needs to be screened?

Authors:  T Kaspar; A Schweiger; S Droz; J Marschall
Journal:  Antimicrob Resist Infect Control       Date:  2015-07-25       Impact factor: 4.887

Review 8.  Importance of antimicrobial stewardship to the English National Health Service.

Authors:  Jill Dixon; Christopher Ja Duncan
Journal:  Infect Drug Resist       Date:  2014-05-30       Impact factor: 4.003

9.  Influx of multidrug-resistant organisms by country-to-country transfer of patients.

Authors:  Nico T Mutters; Frank Günther; Anja Sander; Alexander Mischnik; Uwe Frank
Journal:  BMC Infect Dis       Date:  2015-10-28       Impact factor: 3.090

10.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.

Authors:  Tinja Lääveri; Jessica A Vlot; Alje P van Dam; Hanni K Häkkinen; Gerard J B Sonder; Leo G Visser; Anu Kantele
Journal:  BMC Infect Dis       Date:  2018-07-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.